Clinical Trials and Compassionate Use in Multiple Myeloma
May 26, 2018
Every myeloma treatment available, even our first line therapies, began as a clinical trial. There are so many promising treatments currently in clinical trials, but the process ca...
Jun 14, 2018
Jun 12, 2018
MYELOMA CROWD RADIO
Full Show: Overcoming Proteasome Inhibitor Resistance, Mu...
Jun 12, 2018
[caption id="attachment_19216" align="alignright"...
Clinical Trial: BOSTON Trial, Bortezomib, Selinexor, and ...
May 18, 2018
The BOSTON trial is a phase 3 study comparing weekly oral selinexor + bortezomib + low-dose dexamethasone (SVd) versus bortezomib (twice weekly) + low-dose dexamethasone (Vd) in patients with relapsed or refractory multiple myeloma. Patients whose myeloma progresses o...
Find financial resources like housing, prescription and patient assistance programs and other helpful links that will guide you through your myeloma care.
Patients who are seen by myeloma specialists live longer. Find a myeloma specialists closest to you and add them to your care team for your best outcomes.
Today's myeloma therapies are yesterday's clinical trials and if more patients joined, we could accelerate a cure.Find a trial that's right for you using a myeloma clinical trial finder called SparkCures.
MYELOMA CROWD RESEARCH INITIATIVE
The Myeloma Crowd Research Initiative (MCRI) is a new approach to funding cancer research; combining the skill and knowledge of leading myeloma specialists with the patient perspective and supportive patient social communities to select and fund promising research projects in myeloma. The goal of the MCRI is to find and fund a cure for multiple myeloma.Learn More >
Thanks to our site sponsors: